Pathogenicity of mycobacteria is tightly linked to their survival in host macrophages. Normally, phagocytosed microorganisms are rapidly transferred from phagosomes to lysosomes and degraded. However, pathogenic mycobacteria resist lysosomal delivery and survive within macrophages inside mycobacterial phagosomes (1, 2) . Mycobacterial phagosomes are characterized by the absence of lysosomal markers such as lysosomal associated membrane proteins (LAMP) and mature lysosomal hydrolases (3) (4) (5) . Phagosomes harbouring mycobacteria also contain markers for the early endosomal pathway (6, 7) , have a reduced amount of the vacuolar proton ATPase and retain the WDrepeat containing protein coronin 1 (also known as TACO or P57) that prevents fusion of phagosomes with lysosomes (8) (9) (10) (11) .
How mycobacteria interfere with phagosome-lysosome fusion is not understood (12) (13) (14) . Several lipid moieties arrest phagosomal maturation by interfering with traffic from the Golgi complex (15, 16) but the mycobacterial proteins responsible for interfering with lysosomal delivery remain unknown (17) .
Modulation of host cellular trafficking pathways is possibly influenced by signal transduction molecules expressed by pathogenic bacteria. The Mycobacterium tuberculosis genome encodes 11 eukaryotic-like serine/threonine kinases (18, 19) . Mammalian protein kinase Cα is most closely related to protein kinase G (PknG) (20) . PknG consists of a kinase domain flanked by a large N-and C-terminal domain with unknown function ( fig. S1A ). In contrast to most other mycobacterial serine/threonine kinases, PknG does not contain a transmembrane domain and is predicted to be located in the bacterial cytoplasm (21) . Immunoblotting of a M. bovis BCG or M. smegmatis-pknG using anti-PknG antibodies revealed a 85 kD band that was not present in the non-pathogenic mycobacterium M. smegmatis ( fig. S1B) . Analysis of the kinase activity showed that PknG was autophosphorylated which was blocked in the presence of chelerythrine, similarly to the activity of protein kinase Cα ( fig. S1C) .
To analyze the contribution of PknG to inhibition of lysosomal transfer of M. bovis BCG within macrophages, the pknG gene was deleted (22) . No PknG was found in the deletion strain whereas PknG was readily detected in the cytoplasm of wild type cells (Fig. 1A) (fig. S2 ). The pknG gene was found to be dispensable for mycobacterial growthno differences were observed either in cell morphology or in the growth of the wild type and mutant M. bovis BCG (Fig. 1,  A and B) .
Intracellular trafficking of mycobacteria lacking pknG was analyzed following infection of macrophages with wild type M. bovis BCG or M. bovis BCG∆pknG. Virtually all (~95%) M. bovis BCG∆pknG resided within LAMP positive vacuoles, whereas wild type M. bovis BCG was largely present in LAMP-negative phagosomes (Fig. 1C) . To independently analyze the intracellular location of M. bovis BCG∆pknG, macrophages were infected with wild type M. bovis BCG or M. bovis BCG∆pknG followed by cell fractionation using organelle electrophoresis (9, (23) (24) (25) . M. bovis BCG lacking PknG was present in organelles that were largely resolved in lysosomal fractions, in contrast to the wild type bacteria that were transferred to non-lysosomal organelles (Fig. 1D) .
The rapid lysosomal transfer of mycobacteria lacking PknG could result in their intracellular killing by bactericidal activities present in the lysosomes. When M. bovis BCG or M. bovis BCG∆pknG was internalized into macrophages for 1 hour, followed by a chase, M. bovis BCG readily proliferated within macrophages, but the pknG deletion mutant failed to grow (Fig. 1E) , suggesting a crucial role for PknG in the survival of mycobacteria within macrophages.
The non pathogenic mycobacterium M. smegmatis that does not express PknG was readily transferred to lysosomes upon entry into macrophages (Fig. 2, A (26, 27) , but the bacteria expressing PknG were largely resolved in non-lysosomal fractions (Fig. 2C) .
The ability of PknG to prevent lysosomal transfer suggested that it may affect survival of bacteria that have been internalized in macrophages. Control M. smegmatis was rapidly cleared by macrophages, but survival of M. smegmatis expressing PknG was significantly enhanced (Fig. 2D ). Thus the expression of PknG in M. smegmatis is sufficient to prevent lysosomal transfer and prolong intracellular survival.
To investigate whether the kinase activity of PknG was essential for its activity in avoiding lysosomal transfer the phenotype of mycobacteria expressing a kinase-dead mutant of PknG (PknG K181M (28) , virtually all bacilli were transferred to lysosomes despite normal viability of the bacteria (Fig. 3, A to C) . Infection of macrophages with M. bovis BCG-pknG K181M resulted in efficient killing of the intracellularly residing bacteria, in contrast to wild type or PknG overexpressing bacteria (Fig.  3D ). Thus the kinase activity is essential for the capacity of PknG to prevent lysosomal delivery and to mediate mycobacterial survival within macrophages.
Modulation of phagosome-lysosome fusion by PknG could be mediated through phosphorylation of host proteins following secretion within the macrophage. Although PknG does not contain an identifiable N-terminal signal sequence, many pathogenic microorganisms including Mycobacterium spp. have evolved alternative secretion pathways (29, 30) . To analyze secretion of PknG, macrophages were infected with either live or heat killed M. bovis BCG, followed by preparation of phagosomes and solubilization. PknG was present in the pellet as well in the soluble fraction prepared from phagosomes harbouring viable bacteria (Fig. 3E) but not after internalization of killed mycobacteria (Fig. 3E) . In membrane fractions prepared from macrophages infected with live as well as killed mycobacteria PknG was readily detectable (Fig. 3E) . Also the kinase inactive mutant was secreted, and detected in the cytosol when macrophages were infected with live, but not with killed M. smegmatispknG K181M (Fig. 3F) . Furthermore, immunocytochemistry revealed localization of PknG within phagosomes as well as in the cytosol of macrophages that had internalized live (Fig.  3G ), but not heat killed mycobacteria (Fig. 3H) . Thus, PknG is actively secreted by mycobacteria after uptake into macrophages and acquires access to the macrophage cytosol.
The involvement of the serine/threonine kinase PknG in intracellular trafficking of mycobacteria suggests that inhibition of PknG could alter the intracellular behaviour of the mycobacteria. To search for potential specific inhibitors, a compound library was screened against GST-PknG. A tetrahydrobenzothiophene was identified that specifically inhibited the kinase activity of PknG with an IC 50 value 0.39 µM (AX20017; Fig. 4, A and B) , as opposed to an IC 50 10-100 µM for eight other mycobacterial serine/threonine kinases (table S1). The inhibitor blocked the kinase activity of purified PknG but it had no effect on the kinase activity of protein kinase Cα (Fig. 4C) . The PknG specific inhibitor did not affect macrophage growth characteristics at concentrations up to 20 µM ( fig. S3 ), nor the growth of luminescent M. tuberculosis (Fig. 4D) , suggesting no direct effect of the PknG inhibitor on mycobacterial viability in culture, consistent with the phenotype of the mycobacterial strains lacking the pknG gene. Thus, this screen identified an inhibitor specific for PknG without any adverse effect on macrophages or mycobacterial viability outside host cells.
The presence of the inhibitor during infection of macrophages with mycobacteria caused a dose dependent increase in the lysosomal localization of the mycobacteria (Fig. 4, E and F) . When the intracellular trafficking of mycobacteria in the presence of AX20017 was analyzed by cell fractionation, virtually all intracellularly residing bacteria were resolved in lysosomal fractions (Fig. 4G) . The growth of both M. bovis BCG as well as M. tuberculosis was inhibited in a dose dependent manner inside macrophages (Fig. 4, H  and I) . Thus, chemical targeting of PknG resulted in a phenocopy of deletion of the pknG gene -the bacteria were rapidly transferred to lysosomes and killed within infected macrophages.
The data presented here show that the eukaryotic-like serine/threonine PknG from mycobacteria mediates survival of mycobacteria within macrophages by blocking lysosomal delivery, providing a remarkable example of the co-evolution of pathogenic mycobacteria with their mammalian host cells. Eukaryotic-like serine/threonine kinases have now been found to be encoded by a number of bacterial genomes (31, 32) . The majority of these genes may have been lost in prokaryotes during evolution because they are not needed for bacterial growth (33) . Perhaps the expression of serine/threonine PknG has been maintained by pathogenic mycobacteria because of the selective advantage of avoiding phagosome-lysosome fusion concomitant with mycobacterial survival.
Specific inhibitors of protein kinases have been successfully developed for therapeutic usage against a variety of diseases (34, 35) . The compound that we have identified represents a promising candidate for the development of a class of drugs that would target intracellularly residing mycobacteria and allow the macrophage to carry out its innate bactericidal activity by shuttling these bacteria to lysosomes.
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